Stock Track | Moderna Soars 5.01% Intraday on TD Cowen Target Price Hike and Strategic Shift to Oncology Focus

Stock Track01-29

Moderna, Inc. (MRNA) saw its stock price soar 5.01% during Thursday's intraday trading session.

The significant price movement appears to be driven by a major analyst upgrade and news of a strategic pivot. TD Cowen raised its price target for Moderna to $40 from $25, representing a substantial 60% increase in the firm's valuation outlook for the biotech company.

Concurrently, Moderna announced a shift in its vaccine development strategy, planning to stop self-funding new Phase III vaccine trials in the U.S. and instead seek external partners for late-stage studies. The company is also expanding its focus beyond COVID-19 vaccines into cancer immunotherapy and other disease areas, potentially reducing its reliance on pandemic-era products and creating more balanced revenue drivers over time.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1141951496?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-29 23:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1141951496","market":"us","top_or_hot":-1,"title":"Stock Track | Moderna Soars 5.01% Intraday on TD Cowen Target Price Hike and Strategic Shift to Oncology Focus","media":"Stock Track","content":"<p>Moderna, Inc. (MRNA) saw its stock price soar 5.01% during Thursday's intraday trading session.</p><p>The significant price movement appears to be driven by a major analyst upgrade and news of a strategic pivot. TD Cowen raised its price target for Moderna to $40 from $25, representing a substantial 60% increase in the firm's valuation outlook for the biotech company.</p><p>Concurrently, Moderna announced a shift in its vaccine development strategy, planning to stop self-funding new Phase III vaccine trials in the U.S. and instead seek external partners for late-stage studies. The company is also expanding its focus beyond COVID-19 vaccines into cancer immunotherapy and other disease areas, potentially reducing its reliance on pandemic-era products and creating more balanced revenue drivers over time.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Moderna Soars 5.01% Intraday on TD Cowen Target Price Hike and Strategic Shift to Oncology Focus</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Moderna Soars 5.01% Intraday on TD Cowen Target Price Hike and Strategic Shift to Oncology Focus\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-01-29 23:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Moderna, Inc. (MRNA) saw its stock price soar 5.01% during Thursday's intraday trading session.</p><p>The significant price movement appears to be driven by a major analyst upgrade and news of a strategic pivot. TD Cowen raised its price target for Moderna to $40 from $25, representing a substantial 60% increase in the firm's valuation outlook for the biotech company.</p><p>Concurrently, Moderna announced a shift in its vaccine development strategy, planning to stop self-funding new Phase III vaccine trials in the U.S. and instead seek external partners for late-stage studies. The company is also expanding its focus beyond COVID-19 vaccines into cancer immunotherapy and other disease areas, potentially reducing its reliance on pandemic-era products and creating more balanced revenue drivers over time.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MRNA","symbol_name":"Moderna, Inc.","start_time":0,"source_url":"","article_id":"1141951496","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1141951496","pubTimestamp":1769700757,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Moderna, Inc. (MRNA) saw its stock price soar 5.01% during Thursday's intraday trading session.The significant price movement appears to be driven by a major analyst upgrade and news of a strategic...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MRNA":"Moderna, Inc."},"translate_title":"个股赛道|Moderna盘中大涨5.01%TD Cowen上调目标价战略转向肿瘤重点","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MRNA":1},"content_text":"Moderna, Inc. (MRNA) saw its stock price soar 5.01% during Thursday's intraday trading session.The significant price movement appears to be driven by a major analyst upgrade and news of a strategic pivot. TD Cowen raised its price target for Moderna to $40 from $25, representing a substantial 60% increase in the firm's valuation outlook for the biotech company.Concurrently, Moderna announced a shift in its vaccine development strategy, planning to stop self-funding new Phase III vaccine trials in the U.S. and instead seek external partners for late-stage studies. The company is also expanding its focus beyond COVID-19 vaccines into cancer immunotherapy and other disease areas, potentially reducing its reliance on pandemic-era products and creating more balanced revenue drivers over time.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1141951496","isCrawlerRequest":true}